Systemic therapy for head and neck squamous cell carcinoma: Historical perspectives and recent breakthroughs.

about

Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.

P2860

Q50099281-5740EBD4-E4A7-4D68-A0B8-E6D364AB0FF4

P2860

Systemic therapy for head and neck squamous cell carcinoma: Historical perspectives and recent breakthroughs.

Item

http://www.wikidata.org/entity/Q38744053

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Systemic therapy for head and ...... ives and recent breakthroughs.

@en

type

Item

label

Systemic therapy for head and ...... ives and recent breakthroughs.

@en

prefLabel

Systemic therapy for head and ...... ives and recent breakthroughs.

@en

P1476

Systemic therapy for head and ...... ives and recent breakthroughs.

@en

P2093

Adam J Folbe

http://www.w3.org/2001/XMLSchema#string

Andrew M Fribley

http://www.w3.org/2001/XMLSchema#string

John R Jacobs

http://www.w3.org/2001/XMLSchema#string

Michael A Blasco

http://www.w3.org/2001/XMLSchema#string

Pankhoori Saraf

http://www.w3.org/2001/XMLSchema#string

Peter F Svider

http://www.w3.org/2001/XMLSchema#string

S Naweed Raza

http://www.w3.org/2001/XMLSchema#string

Soly Baredes

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.

P31

scholarly article

P356

10.1002/LARY.26629

http://www.w3.org/2001/XMLSchema#string

P407

English

P50

Jean Anderson Eloy

P577

2017-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28581126

http://www.w3.org/2001/XMLSchema#string

Systemic therapy for head and neck squamous cell carcinoma: Historical perspectives and recent breakthroughs.

about

P2860

P2860

Systemic therapy for head and neck squamous cell carcinoma: Historical perspectives and recent breakthroughs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P50

P577

P698